Table 2.
Engraftment syndrome ES (n = 46) (%) | |
---|---|
Age (median/IQR, in years) | 45.5 years (22–65 years) |
Sex (male) | 26 (56%) |
Diagnosis | |
Myeloma | 23 (50%) |
Hodgkin’s lymphoma | 16 (35%) |
Non-Hodgkin’s lymphoma | 07 (15%) |
Others | 00 |
Conditioning regime | |
BEAM | 6 (14%) |
LACE | 16 (35%) |
CBV | 01 |
Melphalan | 23 (50%) |
Others | 00 |
Median CD34 counts (median, n = 120) | 3.2 |